Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association between treatment adherence and indirect productivity costs within a cohort of commercially insured employees with bipolar disorder in the United States. METHODS: Adults diagnosed with bipolar disorder who had at least one prescription claim for a mood stabilizer or atypical antipsychotic, with 6 months prior and 12 months subsequent continuous medical and prescription coverage, were identified in the MarketScan research databases (2000-2005). Two-part multiple regression models estimated the association between adherence (medication possession ratio > or =0.80) and costs of absence, short-term disability, and workers' compensation. RESULTS: Of 1258 eligible employees, only 35.3% were adherent. Relative to adherent employees, nonadherent employees had higher adjusted indirect costs due to absence (+$771.41), short-term disability (+$284.72), and workers' compensation (+$360.63). CONCLUSIONS: Employers incur greater indirect costs when employees are not adherent to bipolar treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bagalman et al25 focused primarily on the indirect costs associated with non-adherence—short-term disability, workers’ compensation and paid time off costs”
From Economic impact of medication non-adherence by disease groups: a systematic review (2018) · cites this paper as [25]
Citations
Cites
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.692 · Cited by 603
Nonadherence With Mood Stabilizers: Prevalence and Predictors
Scott, J., & Pope, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0502 · Cited by 315
An economic evaluation of manic-depressive illness-1991
Wyatt, R. J., & Henter, I. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789056 · Cited by 312
The Lifetime Cost of Bipolar Disorder in the US: An Estimate for New Cases in 1998
Begley, C. E., Annegers, J. F., Swann, A. C., Lewis, C., Coan, S., Schnapp, W. B., & Bryant-Comstock, L. (2001) · PharmacoEconomics · doi:10.2165/00019053-200119050-00004 · Cited by 265
Treatment adherence with antipsychotic medications in bipolar disorder
Sajatovic, M., Valenstein, M., Blow, F. C., Ganoczy, D., & Ignacio, R. V. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00314.x · Cited by 242
Treatment Adherence With Lithium and Anticonvulsant Medications Among Patients With Bipolar Disorder
Sajatovic, M., Valenstein, M., Blow, F., Ganoczy, D., & Ignacio, R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.855 · Cited by 172
Bipolar disorder: disease burden.
Sajatovic, M. (2005) · PubMed · Cited by 115
The Economic Impact of Bipolar Disorder in an Employed Population From an Employer Perspective
Gardner, H. H., Kleinman, N. L., Brook, R. A., Rajagopalan, K., Brizee, T. J., & Smeeding, J. E. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0806 · Cited by 104
Ahn, J., McCombs, J. S., Jung, C., Croudace, T. J., McDonnell, D., Ascher‐Svanum, H., Edgell, E. T., & Shi, L. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00214.x · Cited by 84
Lage, M. J., & Hassan, M. K. (2009) · Annals of General Psychiatry · doi:10.1186/1744-859x-8-7 · Cited by 71
Hassan, M., & Lage, M. J. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080374 · Cited by 67
Bipolar disorder and work loss.
Bowden, C. L. (2005) · PubMed · Cited by 52
Gianfrancesco, F. D., Rajagopalan, K., Sajatovic, M., & Wang, R.-H. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0208 · Cited by 45
Medication Adherence and the Use of Long-Acting Antipsychotics in Bipolar Disorder
EL-MALLAKH, R. S. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265764.87376.02 · Cited by 40
The effect of medication adherence on health care utilization in bipolar disorder.
Lew, K. H., Chang, E. Y., Rajagopalan, K., & Knoth, R. L. (2006) · PubMed · Cited by 37
Woltmann, E. M., Valenstein, M. M., Welsh, D. E., Lee, T. A., Wolschon, P. A., Grabowski, J. G., & Reilly, P. A. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.6.864 · Cited by 32
Hassan, M., Madhavan, S. S., Kalsekar, I. D., Makela, E. H., Rajagopalan, K., Islam, S., Kavookjian, J., & Miller, L. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k205 · Cited by 25
Employee costs before and after treatment initiation for bipolar disorder.
Brook, R. A., Kleinman, N. L., & Rajagopalan, K. (2007) · PubMed · Cited by 11
Impact of Bipolar Disorder on Employers: Rationale for Workplace Interventions
Montejano, L. B., Goetzel, R. Z., & Ozminkowski, R. J. (2005) · Disease Management & Health Outcomes · doi:10.2165/00115677-200513040-00005 · Cited by 7
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147
Mood disorders medications: predictors of nonadherence – review of the current literature
Pompili, M., Venturini, P., Palermo, M., Stefani, H., Seretti, M. E., Lamis, D. A., Serafini, G., Amore, M., & Girardi, P. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811976 · Cited by 120
“…questionnaire: the BMQ BD Younger age, more medications, patients’ belief about treatment and illness in regard to its consequences and timeline [11] Bagalman et al. (2010) I = 1 II = 2 III = 22 IV = 2 V = 1 VI = 2 Total score = 10 Cohort study Prescription records: MPR BD Have a recent diagnosis…”
BackgroundCuevas, C. D. L., de León, J., Peñate, W., & Betancort, M. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s133513 · Cited by 70
“17,18 21 Previous research has shown that treatment adherence is a multidimensional phenomenon determined by the interplay of different factors including patient-related, environment-related, medication-related, disorder-related, and other treatment-related factors.”
Metadata
- Authors
- Bagalman, E., Yu-Isenberg, K. S., Durden, E., Crivera, C., Dirani, R., & Bunn, W. B.
- Affiliations
- Thomson Reuters (United States) (US)
- Northwestern University (US)
- Corresponding author
- Bagalman, Erin
- ORCID
- Durden, Emily
- Venue
- Journal of Occupational & Environmental Medicine
- Published
- 2010-05
- Volume
- 52
- Issue
- 5
- Pages
- 478-485
- ISSN
- 1076-2752 (ISSN-L)
- OpenAlex
- W1972371326
- Cited by
- 32
- References
- 22
- Citations by year
- 2026: 2 · 2025: 2 · 2022: 2 · 2021: 2 · 2020: 5 · 2018: 2 · 2017: 2 · 2016: 3 · 2014: 2 · 2013: 5 · 2012: 3
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Occupational and Environmental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- bipolar disorder, medication adherence, indirect costs, productivity costs, absenteeism, short-term disability, workers' compensation, mood stabilizers, atypical antipsychotics, employer costs
- MeSH terms
- Adolescent, Adult, Bipolar Disorder, Costs and Cost Analysis, Female, Humans, Male, Middle Aged, Patient Compliance, United States, Workers' Compensation, Databases, Factual, Sick Leave, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.